DuChemBIO Co.,Ltd. (KOSDAQ:176750)

DuChemBIO Statistics

Total Valuation

DuChemBIO has a market cap or net worth of KRW 272.96 billion. The enterprise value is 274.31 billion.

Market Cap	272.96B
Enterprise Value	274.31B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

DuChemBIO has 28.34 million shares outstanding. The number of shares has increased by 5.49% in one year.

Current Share Class	28.34M
Shares Outstanding	28.34M
Shares Change (YoY)	+5.49%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	9.36%
Owned by Institutions (%)	0.04%
Float	11.01M

Valuation Ratios

The trailing PE ratio is 35.11 and the forward PE ratio is 17.41.

PE Ratio	35.11
Forward PE	17.41
PS Ratio	7.33
PB Ratio	5.90
P/TBV Ratio	9.70
P/FCF Ratio	38.84
P/OCF Ratio	32.36
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.55, with an EV/FCF ratio of 39.03.

EV / Earnings	35.44
EV / Sales	7.36
EV / EBITDA	22.55
EV / EBIT	43.09
EV / FCF	39.03

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.34.

Current Ratio	1.88
Quick Ratio	1.78
Debt / Equity	0.34
Debt / EBITDA	1.36
Debt / FCF	2.23
Interest Coverage	6.36

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	10.73%
Revenue Per Employee	295.60M
Profits Per Employee	61.43M
Employee Count	126
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.79B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.05% in the last 52 weeks. The beta is -0.09, so DuChemBIO's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-30.05%
50-Day Moving Average	9,712.60
200-Day Moving Average	10,633.30
Relative Strength Index (RSI)	48.80
Average Volume (20 Days)	58,014

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DuChemBIO had revenue of KRW 37.25 billion and earned 7.74 billion in profits. Earnings per share was 274.28.

Revenue	37.25B
Gross Profit	13.02B
Operating Income	5.72B
Pretax Income	5.95B
Net Income	7.74B
EBITDA	11.52B
EBIT	5.72B
Earnings Per Share (EPS)	274.28

Balance Sheet

The company has 14.31 billion in cash and 15.66 billion in debt, giving a net cash position of -1.35 billion or -47.47 per share.

Cash & Cash Equivalents	14.31B
Total Debt	15.66B
Net Cash	-1.35B
Net Cash Per Share	-47.47
Equity (Book Value)	46.23B
Book Value Per Share	1,643.78
Working Capital	12.92B

Cash Flow

In the last 12 months, operating cash flow was 8.43 billion and capital expenditures -1.41 billion, giving a free cash flow of 7.03 billion.

Operating Cash Flow	8.43B
Capital Expenditures	-1.41B
Free Cash Flow	7.03B
FCF Per Share	247.94

Margins

Gross margin is 34.96%, with operating and profit margins of 15.37% and 20.78%.

Gross Margin	34.96%
Operating Margin	15.37%
Pretax Margin	15.98%
Profit Margin	20.78%
EBITDA Margin	30.93%
EBIT Margin	15.37%
FCF Margin	18.87%

Dividends & Yields

DuChemBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.49%
Shareholder Yield	-5.49%
Earnings Yield	2.84%
FCF Yield	2.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DuChemBIO has an Altman Z-Score of 10.32 and a Piotroski F-Score of 5.

Altman Z-Score	10.32
Piotroski F-Score	5